2015
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Hicks K, Tcheng J, Bozkurt B, Chaitman B, Cutlip D, Farb A, Fonarow G, Jacobs J, Jaff M, Lichtman J, Limacher M, Mahaffey K, Mehran R, Nissen S, Smith E, Targum S. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Journal Of Nuclear Cardiology 2015, 22: 1041-1144. PMID: 26204990, DOI: 10.1007/s12350-015-0209-1.Peer-Reviewed Original ResearchMeSH KeywordsAmerican Heart AssociationCardiologyCardiovascular DiseasesClinical Trials as TopicCommon Data ElementsConfidentialityDatabases, FactualEndpoint DeterminationHealth Insurance Portability and Accountability ActHumansQuality Assurance, Health CareQuality of Health CareReproducibility of ResultsResearch DesignSocieties, MedicalTerminology as TopicTranslational Research, BiomedicalTreatment OutcomeUnited States
2001
Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Johnston S, Fung L, Gillum L, Smith W, Brass L, Lichtman J, Brown A. Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers. Stroke 2001, 32: 1061-1068. PMID: 11340210, DOI: 10.1161/01.str.32.5.1061.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAgedBlack or African AmericanBrain IschemiaCohort StudiesContraindicationsDatabases, FactualDrug Utilization ReviewFemaleFibrinolytic AgentsHumansLogistic ModelsMaleMiddle AgedPatient DischargeStrokeThrombolytic TherapyTissue Plasminogen ActivatorUnited StatesWhite PeopleConceptsAcademic medical centerTissue-type plasminogen activatorIschemic strokeMedical CenterIntravenous tissue-type plasminogen activatorConsecutive ischemic stroke casesAfrican AmericansPlasminogen activatorIschemic stroke patientsUS academic medical centersMultivariable logistic regressionMedical insuranceIschemic stroke casesMedical insurance typePrivate medical insuranceTPA useStroke severityStroke patientsStroke casesMedical historyInsurance typeMedical recordsUnivariate analysisContraindicationsLogistic regression